Global Single-Domain Heavy Chain Antibody Market Growth 2025-2031
Product Code: 1394459
Industry: Pharma & Healthcare
Published: Mar 07,2025
Pages: 119
Delivery Time: 2-3 business days
Global Single-Domain Heavy Chain Antibody Market Growth 2025-2031
Product Code: 1394459
Industry: Pharma & Healthcare
Published: Mar 07,2025
Pages: 119
Delivery Time: 2-3 business days
Select A Format
Single User License
USD3660
Multi Users License
USD5490
Corporate Users License
USD7320
Buy Now
Add To Cart
Or More Options：
PDF Download
Sample Request
Custom Request
Description
The global Single-Domain Heavy Chain Antibody market size is predicted to grow from US$ 1360 million in 2025 to US$ 2309 million in 2031; it is expected to grow at a CAGR of 9.2% from 2025 to 2031.
A single-domain heavy chain antibody is a type of antibody consisting of only one variable domain derived from the heavy chain of a traditional antibody. Unlike conventional antibodies that are composed of both heavy and light chains, single-domain antibodies (sdAbs) are smaller and more stable. These antibodies are derived from the variable regions of heavy chain antibodies found in camelids (such as camels and alpacas) and can be used in various applications, including diagnostics, therapeutics, and research, due to their high specificity, stability, and ability to bind to targets that conventional antibodies cannot.
United States market for Single-Domain Heavy Chain Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Single-Domain Heavy Chain Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Single-Domain Heavy Chain Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Single-Domain Heavy Chain Antibody players cover Sino Biological, GenScript, Proteintech Group, Abiocenter, MerryBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Single-Domain Heavy Chain Antibody Industry Forecast” looks at past sales and reviews total world Single-Domain Heavy Chain Antibody sales in 2024, providing a comprehensive analysis by region and market sector of projected Single-Domain Heavy Chain Antibody sales for 2025 through 2031. With Single-Domain Heavy Chain Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Single-Domain Heavy Chain Antibody industry.
This Insight Report provides a comprehensive analysis of the global Single-Domain Heavy Chain Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Single-Domain Heavy Chain Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Single-Domain Heavy Chain Antibody market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Single-Domain Heavy Chain Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Single-Domain Heavy Chain Antibody.
This report presents a comprehensive overview, market shares, and growth opportunities of Single-Domain Heavy Chain Antibody market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Natural Single-Domain Heavy Chain Antibody
Recombinant Single-Domain Heavy Chain Antibody
Segmentation by Application:
Treatment
Diagnosis
Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sino Biological
GenScript
Proteintech Group
Abiocenter
MerryBio
Pregene
Cusabio
Biocytogen
Thermo Fisher Scientific
QVQuality
HUABIO
Jackson ImmunoResearch
Key Questions Addressed in this Report
What is the 10-year outlook for the global Single-Domain Heavy Chain Antibody market?
What factors are driving Single-Domain Heavy Chain Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Single-Domain Heavy Chain Antibody market opportunities vary by end market size?
How does Single-Domain Heavy Chain Antibody break out by Type, by Application?
Table Of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Single-Domain Heavy Chain Antibody Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Single-Domain Heavy Chain Antibody by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Single-Domain Heavy Chain Antibody by Country/Region, 2020, 2024 & 2031
2.2 Single-Domain Heavy Chain Antibody Segment by Type
2.2.1 Natural Single-Domain Heavy Chain Antibody
2.2.2 Recombinant Single-Domain Heavy Chain Antibody
2.3 Single-Domain Heavy Chain Antibody Sales by Type
2.3.1 Global Single-Domain Heavy Chain Antibody Sales Market Share by Type (2020-2025)
2.3.2 Global Single-Domain Heavy Chain Antibody Revenue and Market Share by Type (2020-2025)
2.3.3 Global Single-Domain Heavy Chain Antibody Sale Price by Type (2020-2025)
2.4 Single-Domain Heavy Chain Antibody Segment by Application
2.4.1 Treatment
2.4.2 Diagnosis
2.4.3 Research
2.5 Single-Domain Heavy Chain Antibody Sales by Application
2.5.1 Global Single-Domain Heavy Chain Antibody Sale Market Share by Application (2020-2025)
2.5.2 Global Single-Domain Heavy Chain Antibody Revenue and Market Share by Application (2020-2025)
2.5.3 Global Single-Domain Heavy Chain Antibody Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Single-Domain Heavy Chain Antibody Breakdown Data by Company
3.1.1 Global Single-Domain Heavy Chain Antibody Annual Sales by Company (2020-2025)
3.1.2 Global Single-Domain Heavy Chain Antibody Sales Market Share by Company (2020-2025)
3.2 Global Single-Domain Heavy Chain Antibody Annual Revenue by Company (2020-2025)
3.2.1 Global Single-Domain Heavy Chain Antibody Revenue by Company (2020-2025)
3.2.2 Global Single-Domain Heavy Chain Antibody Revenue Market Share by Company (2020-2025)
3.3 Global Single-Domain Heavy Chain Antibody Sale Price by Company
3.4 Key Manufacturers Single-Domain Heavy Chain Antibody Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Single-Domain Heavy Chain Antibody Product Location Distribution
3.4.2 Players Single-Domain Heavy Chain Antibody Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Single-Domain Heavy Chain Antibody by Geographic Region
4.1 World Historic Single-Domain Heavy Chain Antibody Market Size by Geographic Region (2020-2025)
4.1.1 Global Single-Domain Heavy Chain Antibody Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Single-Domain Heavy Chain Antibody Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Single-Domain Heavy Chain Antibody Market Size by Country/Region (2020-2025)
4.2.1 Global Single-Domain Heavy Chain Antibody Annual Sales by Country/Region (2020-2025)
4.2.2 Global Single-Domain Heavy Chain Antibody Annual Revenue by Country/Region (2020-2025)
4.3 Americas Single-Domain Heavy Chain Antibody Sales Growth
4.4 APAC Single-Domain Heavy Chain Antibody Sales Growth
4.5 Europe Single-Domain Heavy Chain Antibody Sales Growth
4.6 Middle East & Africa Single-Domain Heavy Chain Antibody Sales Growth
5 Americas
5.1 Americas Single-Domain Heavy Chain Antibody Sales by Country
5.1.1 Americas Single-Domain Heavy Chain Antibody Sales by Country (2020-2025)
5.1.2 Americas Single-Domain Heavy Chain Antibody Revenue by Country (2020-2025)
5.2 Americas Single-Domain Heavy Chain Antibody Sales by Type (2020-2025)
5.3 Americas Single-Domain Heavy Chain Antibody Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Single-Domain Heavy Chain Antibody Sales by Region
6.1.1 APAC Single-Domain Heavy Chain Antibody Sales by Region (2020-2025)
6.1.2 APAC Single-Domain Heavy Chain Antibody Revenue by Region (2020-2025)
6.2 APAC Single-Domain Heavy Chain Antibody Sales by Type (2020-2025)
6.3 APAC Single-Domain Heavy Chain Antibody Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Single-Domain Heavy Chain Antibody by Country
7.1.1 Europe Single-Domain Heavy Chain Antibody Sales by Country (2020-2025)
7.1.2 Europe Single-Domain Heavy Chain Antibody Revenue by Country (2020-2025)
7.2 Europe Single-Domain Heavy Chain Antibody Sales by Type (2020-2025)
7.3 Europe Single-Domain Heavy Chain Antibody Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Single-Domain Heavy Chain Antibody by Country
8.1.1 Middle East & Africa Single-Domain Heavy Chain Antibody Sales by Country (2020-2025)
8.1.2 Middle East & Africa Single-Domain Heavy Chain Antibody Revenue by Country (2020-2025)
8.2 Middle East & Africa Single-Domain Heavy Chain Antibody Sales by Type (2020-2025)
8.3 Middle East & Africa Single-Domain Heavy Chain Antibody Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Single-Domain Heavy Chain Antibody
10.3 Manufacturing Process Analysis of Single-Domain Heavy Chain Antibody
10.4 Industry Chain Structure of Single-Domain Heavy Chain Antibody
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Single-Domain Heavy Chain Antibody Distributors
11.3 Single-Domain Heavy Chain Antibody Customer
12 World Forecast Review for Single-Domain Heavy Chain Antibody by Geographic Region
12.1 Global Single-Domain Heavy Chain Antibody Market Size Forecast by Region
12.1.1 Global Single-Domain Heavy Chain Antibody Forecast by Region (2026-2031)
12.1.2 Global Single-Domain Heavy Chain Antibody Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Single-Domain Heavy Chain Antibody Forecast by Type (2026-2031)
12.7 Global Single-Domain Heavy Chain Antibody Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Sino Biological
13.1.1 Sino Biological Company Information
13.1.2 Sino Biological Single-Domain Heavy Chain Antibody Product Portfolios and Specifications
13.1.3 Sino Biological Single-Domain Heavy Chain Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Sino Biological Main Business Overview
13.1.5 Sino Biological Latest Developments
13.2 GenScript
13.2.1 GenScript Company Information
13.2.2 GenScript Single-Domain Heavy Chain Antibody Product Portfolios and Specifications
13.2.3 GenScript Single-Domain Heavy Chain Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 GenScript Main Business Overview
13.2.5 GenScript Latest Developments
13.3 Proteintech Group
13.3.1 Proteintech Group Company Information
13.3.2 Proteintech Group Single-Domain Heavy Chain Antibody Product Portfolios and Specifications
13.3.3 Proteintech Group Single-Domain Heavy Chain Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Proteintech Group Main Business Overview
13.3.5 Proteintech Group Latest Developments
13.4 Abiocenter
13.4.1 Abiocenter Company Information
13.4.2 Abiocenter Single-Domain Heavy Chain Antibody Product Portfolios and Specifications
13.4.3 Abiocenter Single-Domain Heavy Chain Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Abiocenter Main Business Overview
13.4.5 Abiocenter Latest Developments
13.5 MerryBio
13.5.1 MerryBio Company Information
13.5.2 MerryBio Single-Domain Heavy Chain Antibody Product Portfolios and Specifications
13.5.3 MerryBio Single-Domain Heavy Chain Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 MerryBio Main Business Overview
13.5.5 MerryBio Latest Developments
13.6 Pregene
13.6.1 Pregene Company Information
13.6.2 Pregene Single-Domain Heavy Chain Antibody Product Portfolios and Specifications
13.6.3 Pregene Single-Domain Heavy Chain Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Pregene Main Business Overview
13.6.5 Pregene Latest Developments
13.7 Cusabio
13.7.1 Cusabio Company Information
13.7.2 Cusabio Single-Domain Heavy Chain Antibody Product Portfolios and Specifications
13.7.3 Cusabio Single-Domain Heavy Chain Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Cusabio Main Business Overview
13.7.5 Cusabio Latest Developments
13.8 Biocytogen
13.8.1 Biocytogen Company Information
13.8.2 Biocytogen Single-Domain Heavy Chain Antibody Product Portfolios and Specifications
13.8.3 Biocytogen Single-Domain Heavy Chain Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Biocytogen Main Business Overview
13.8.5 Biocytogen Latest Developments
13.9 Thermo Fisher Scientific
13.9.1 Thermo Fisher Scientific Company Information
13.9.2 Thermo Fisher Scientific Single-Domain Heavy Chain Antibody Product Portfolios and Specifications
13.9.3 Thermo Fisher Scientific Single-Domain Heavy Chain Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Thermo Fisher Scientific Main Business Overview
13.9.5 Thermo Fisher Scientific Latest Developments
13.10 QVQuality
13.10.1 QVQuality Company Information
13.10.2 QVQuality Single-Domain Heavy Chain Antibody Product Portfolios and Specifications
13.10.3 QVQuality Single-Domain Heavy Chain Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 QVQuality Main Business Overview
13.10.5 QVQuality Latest Developments
13.11 HUABIO
13.11.1 HUABIO Company Information
13.11.2 HUABIO Single-Domain Heavy Chain Antibody Product Portfolios and Specifications
13.11.3 HUABIO Single-Domain Heavy Chain Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 HUABIO Main Business Overview
13.11.5 HUABIO Latest Developments
13.12 Jackson ImmunoResearch
13.12.1 Jackson ImmunoResearch Company Information
13.12.2 Jackson ImmunoResearch Single-Domain Heavy Chain Antibody Product Portfolios and Specifications
13.12.3 Jackson ImmunoResearch Single-Domain Heavy Chain Antibody Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Jackson ImmunoResearch Main Business Overview
13.12.5 Jackson ImmunoResearch Latest Developments
14 Research Findings and Conclusion
List Of Tables
List of Tables Table 1. Single-Domain Heavy Chain Antibody Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions) Table 2. Single-Domain Heavy Chain Antibody Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions) Table 3. Major Players of Natural Single-Domain Heavy Chain Antibody Table 4. Major Players of Recombinant Single-Domain Heavy Chain Antibody Table 5. Global Single-Domain Heavy Chain Antibody Sales by Type (2020-2025) & (K Units) Table 6. Global Single-Domain Heavy Chain Antibody Sales Market Share by Type (2020-2025) Table 7. Global Single-Domain Heavy Chain Antibody Revenue by Type (2020-2025) & ($ million) Table 8. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Type (2020-2025) Table 9. Global Single-Domain Heavy Chain Antibody Sale Price by Type (2020-2025) & (US$/Unit) Table 10. Global Single-Domain Heavy Chain Antibody Sale by Application (2020-2025) & (K Units) Table 11. Global Single-Domain Heavy Chain Antibody Sale Market Share by Application (2020-2025) Table 12. Global Single-Domain Heavy Chain Antibody Revenue by Application (2020-2025) & ($ million) Table 13. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Application (2020-2025) Table 14. Global Single-Domain Heavy Chain Antibody Sale Price by Application (2020-2025) & (US$/Unit) Table 15. Global Single-Domain Heavy Chain Antibody Sales by Company (2020-2025) & (K Units) Table 16. Global Single-Domain Heavy Chain Antibody Sales Market Share by Company (2020-2025) Table 17. Global Single-Domain Heavy Chain Antibody Revenue by Company (2020-2025) & ($ millions) Table 18. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Company (2020-2025) Table 19. Global Single-Domain Heavy Chain Antibody Sale Price by Company (2020-2025) & (US$/Unit) Table 20. Key Manufacturers Single-Domain Heavy Chain Antibody Producing Area Distribution and Sales Area Table 21. Players Single-Domain Heavy Chain Antibody Products Offered Table 22. Single-Domain Heavy Chain Antibody Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) Table 23. New Products and Potential Entrants Table 24. Market M&A Activity & Strategy Table 25. Global Single-Domain Heavy Chain Antibody Sales by Geographic Region (2020-2025) & (K Units) Table 26. Global Single-Domain Heavy Chain Antibody Sales Market Share Geographic Region (2020-2025) Table 27. Global Single-Domain Heavy Chain Antibody Revenue by Geographic Region (2020-2025) & ($ millions) Table 28. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Geographic Region (2020-2025) Table 29. Global Single-Domain Heavy Chain Antibody Sales by Country/Region (2020-2025) & (K Units) Table 30. Global Single-Domain Heavy Chain Antibody Sales Market Share by Country/Region (2020-2025) Table 31. Global Single-Domain Heavy Chain Antibody Revenue by Country/Region (2020-2025) & ($ millions) Table 32. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Country/Region (2020-2025) Table 33. Americas Single-Domain Heavy Chain Antibody Sales by Country (2020-2025) & (K Units) Table 34. Americas Single-Domain Heavy Chain Antibody Sales Market Share by Country (2020-2025) Table 35. Americas Single-Domain Heavy Chain Antibody Revenue by Country (2020-2025) & ($ millions) Table 36. Americas Single-Domain Heavy Chain Antibody Sales by Type (2020-2025) & (K Units) Table 37. Americas Single-Domain Heavy Chain Antibody Sales by Application (2020-2025) & (K Units) Table 38. APAC Single-Domain Heavy Chain Antibody Sales by Region (2020-2025) & (K Units) Table 39. APAC Single-Domain Heavy Chain Antibody Sales Market Share by Region (2020-2025) Table 40. APAC Single-Domain Heavy Chain Antibody Revenue by Region (2020-2025) & ($ millions) Table 41. APAC Single-Domain Heavy Chain Antibody Sales by Type (2020-2025) & (K Units) Table 42. APAC Single-Domain Heavy Chain Antibody Sales by Application (2020-2025) & (K Units) Table 43. Europe Single-Domain Heavy Chain Antibody Sales by Country (2020-2025) & (K Units) Table 44. Europe Single-Domain Heavy Chain Antibody Revenue by Country (2020-2025) & ($ millions) Table 45. Europe Single-Domain Heavy Chain Antibody Sales by Type (2020-2025) & (K Units) Table 46. Europe Single-Domain Heavy Chain Antibody Sales by Application (2020-2025) & (K Units) Table 47. Middle East & Africa Single-Domain Heavy Chain Antibody Sales by Country (2020-2025) & (K Units) Table 48. Middle East & Africa Single-Domain Heavy Chain Antibody Revenue Market Share by Country (2020-2025) Table 49. Middle East & Africa Single-Domain Heavy Chain Antibody Sales by Type (2020-2025) & (K Units) Table 50. Middle East & Africa Single-Domain Heavy Chain Antibody Sales by Application (2020-2025) & (K Units) Table 51. Key Market Drivers & Growth Opportunities of Single-Domain Heavy Chain Antibody Table 52. Key Market Challenges & Risks of Single-Domain Heavy Chain Antibody Table 53. Key Industry Trends of Single-Domain Heavy Chain Antibody Table 54. Single-Domain Heavy Chain Antibody Raw Material Table 55. Key Suppliers of Raw Materials Table 56. Single-Domain Heavy Chain Antibody Distributors List Table 57. Single-Domain Heavy Chain Antibody Customer List Table 58. Global Single-Domain Heavy Chain Antibody Sales Forecast by Region (2026-2031) & (K Units) Table 59. Global Single-Domain Heavy Chain Antibody Revenue Forecast by Region (2026-2031) & ($ millions) Table 60. Americas Single-Domain Heavy Chain Antibody Sales Forecast by Country (2026-2031) & (K Units) Table 61. Americas Single-Domain Heavy Chain Antibody Annual Revenue Forecast by Country (2026-2031) & ($ millions) Table 62. APAC Single-Domain Heavy Chain Antibody Sales Forecast by Region (2026-2031) & (K Units) Table 63. APAC Single-Domain Heavy Chain Antibody Annual Revenue Forecast by Region (2026-2031) & ($ millions) Table 64. Europe Single-Domain Heavy Chain Antibody Sales Forecast by Country (2026-2031) & (K Units) Table 65. Europe Single-Domain Heavy Chain Antibody Revenue Forecast by Country (2026-2031) & ($ millions) Table 66. Middle East & Africa Single-Domain Heavy Chain Antibody Sales Forecast by Country (2026-2031) & (K Units) Table 67. Middle East & Africa Single-Domain Heavy Chain Antibody Revenue Forecast by Country (2026-2031) & ($ millions) Table 68. Global Single-Domain Heavy Chain Antibody Sales Forecast by Type (2026-2031) & (K Units) Table 69. Global Single-Domain Heavy Chain Antibody Revenue Forecast by Type (2026-2031) & ($ millions) Table 70. Global Single-Domain Heavy Chain Antibody Sales Forecast by Application (2026-2031) & (K Units) Table 71. Global Single-Domain Heavy Chain Antibody Revenue Forecast by Application (2026-2031) & ($ millions) Table 72. Sino Biological Basic Information, Single-Domain Heavy Chain Antibody Manufacturing Base, Sales Area and Its Competitors Table 73. Sino Biological Single-Domain Heavy Chain Antibody Product Portfolios and Specifications Table 74. Sino Biological Single-Domain Heavy Chain Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 75. Sino Biological Main Business Table 76. Sino Biological Latest Developments Table 77. GenScript Basic Information, Single-Domain Heavy Chain Antibody Manufacturing Base, Sales Area and Its Competitors Table 78. GenScript Single-Domain Heavy Chain Antibody Product Portfolios and Specifications Table 79. GenScript Single-Domain Heavy Chain Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 80. GenScript Main Business Table 81. GenScript Latest Developments Table 82. Proteintech Group Basic Information, Single-Domain Heavy Chain Antibody Manufacturing Base, Sales Area and Its Competitors Table 83. Proteintech Group Single-Domain Heavy Chain Antibody Product Portfolios and Specifications Table 84. Proteintech Group Single-Domain Heavy Chain Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 85. Proteintech Group Main Business Table 86. Proteintech Group Latest Developments Table 87. Abiocenter Basic Information, Single-Domain Heavy Chain Antibody Manufacturing Base, Sales Area and Its Competitors Table 88. Abiocenter Single-Domain Heavy Chain Antibody Product Portfolios and Specifications Table 89. Abiocenter Single-Domain Heavy Chain Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 90. Abiocenter Main Business Table 91. Abiocenter Latest Developments Table 92. MerryBio Basic Information, Single-Domain Heavy Chain Antibody Manufacturing Base, Sales Area and Its Competitors Table 93. MerryBio Single-Domain Heavy Chain Antibody Product Portfolios and Specifications Table 94. MerryBio Single-Domain Heavy Chain Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 95. MerryBio Main Business Table 96. MerryBio Latest Developments Table 97. Pregene Basic Information, Single-Domain Heavy Chain Antibody Manufacturing Base, Sales Area and Its Competitors Table 98. Pregene Single-Domain Heavy Chain Antibody Product Portfolios and Specifications Table 99. Pregene Single-Domain Heavy Chain Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 100. Pregene Main Business Table 101. Pregene Latest Developments Table 102. Cusabio Basic Information, Single-Domain Heavy Chain Antibody Manufacturing Base, Sales Area and Its Competitors Table 103. Cusabio Single-Domain Heavy Chain Antibody Product Portfolios and Specifications Table 104. Cusabio Single-Domain Heavy Chain Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 105. Cusabio Main Business Table 106. Cusabio Latest Developments Table 107. Biocytogen Basic Information, Single-Domain Heavy Chain Antibody Manufacturing Base, Sales Area and Its Competitors Table 108. Biocytogen Single-Domain Heavy Chain Antibody Product Portfolios and Specifications Table 109. Biocytogen Single-Domain Heavy Chain Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 110. Biocytogen Main Business Table 111. Biocytogen Latest Developments Table 112. Thermo Fisher Scientific Basic Information, Single-Domain Heavy Chain Antibody Manufacturing Base, Sales Area and Its Competitors Table 113. Thermo Fisher Scientific Single-Domain Heavy Chain Antibody Product Portfolios and Specifications Table 114. Thermo Fisher Scientific Single-Domain Heavy Chain Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 115. Thermo Fisher Scientific Main Business Table 116. Thermo Fisher Scientific Latest Developments Table 117. QVQuality Basic Information, Single-Domain Heavy Chain Antibody Manufacturing Base, Sales Area and Its Competitors Table 118. QVQuality Single-Domain Heavy Chain Antibody Product Portfolios and Specifications Table 119. QVQuality Single-Domain Heavy Chain Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 120. QVQuality Main Business Table 121. QVQuality Latest Developments Table 122. HUABIO Basic Information, Single-Domain Heavy Chain Antibody Manufacturing Base, Sales Area and Its Competitors Table 123. HUABIO Single-Domain Heavy Chain Antibody Product Portfolios and Specifications Table 124. HUABIO Single-Domain Heavy Chain Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 125. HUABIO Main Business Table 126. HUABIO Latest Developments Table 127. Jackson ImmunoResearch Basic Information, Single-Domain Heavy Chain Antibody Manufacturing Base, Sales Area and Its Competitors Table 128. Jackson ImmunoResearch Single-Domain Heavy Chain Antibody Product Portfolios and Specifications Table 129. Jackson ImmunoResearch Single-Domain Heavy Chain Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2025) Table 130. Jackson ImmunoResearch Main Business Table 131. Jackson ImmunoResearch Latest Developments List of Figures Figure 1. Picture of Single-Domain Heavy Chain Antibody Figure 2. Single-Domain Heavy Chain Antibody Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Single-Domain Heavy Chain Antibody Sales Growth Rate 2020-2031 (K Units) Figure 7. Global Single-Domain Heavy Chain Antibody Revenue Growth Rate 2020-2031 ($ millions) Figure 8. Single-Domain Heavy Chain Antibody Sales by Geographic Region (2020, 2024 & 2031) & ($ millions) Figure 9. Single-Domain Heavy Chain Antibody Sales Market Share by Country/Region (2024) Figure 10. Single-Domain Heavy Chain Antibody Sales Market Share by Country/Region (2020, 2024 & 2031) Figure 11. Product Picture of Natural Single-Domain Heavy Chain Antibody Figure 12. Product Picture of Recombinant Single-Domain Heavy Chain Antibody Figure 13. Global Single-Domain Heavy Chain Antibody Sales Market Share by Type in 2025 Figure 14. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Type (2020-2025) Figure 15. Single-Domain Heavy Chain Antibody Consumed in Treatment Figure 16. Global Single-Domain Heavy Chain Antibody Market: Treatment (2020-2025) & (K Units) Figure 17. Single-Domain Heavy Chain Antibody Consumed in Diagnosis Figure 18. Global Single-Domain Heavy Chain Antibody Market: Diagnosis (2020-2025) & (K Units) Figure 19. Single-Domain Heavy Chain Antibody Consumed in Research Figure 20. Global Single-Domain Heavy Chain Antibody Market: Research (2020-2025) & (K Units) Figure 21. Global Single-Domain Heavy Chain Antibody Sale Market Share by Application (2024) Figure 22. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Application in 2025 Figure 23. Single-Domain Heavy Chain Antibody Sales by Company in 2025 (K Units) Figure 24. Global Single-Domain Heavy Chain Antibody Sales Market Share by Company in 2025 Figure 25. Single-Domain Heavy Chain Antibody Revenue by Company in 2025 ($ millions) Figure 26. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Company in 2025 Figure 27. Global Single-Domain Heavy Chain Antibody Sales Market Share by Geographic Region (2020-2025) Figure 28. Global Single-Domain Heavy Chain Antibody Revenue Market Share by Geographic Region in 2025 Figure 29. Americas Single-Domain Heavy Chain Antibody Sales 2020-2025 (K Units) Figure 30. Americas Single-Domain Heavy Chain Antibody Revenue 2020-2025 ($ millions) Figure 31. APAC Single-Domain Heavy Chain Antibody Sales 2020-2025 (K Units) Figure 32. APAC Single-Domain Heavy Chain Antibody Revenue 2020-2025 ($ millions) Figure 33. Europe Single-Domain Heavy Chain Antibody Sales 2020-2025 (K Units) Figure 34. Europe Single-Domain Heavy Chain Antibody Revenue 2020-2025 ($ millions) Figure 35. Middle East & Africa Single-Domain Heavy Chain Antibody Sales 2020-2025 (K Units) Figure 36. Middle East & Africa Single-Domain Heavy Chain Antibody Revenue 2020-2025 ($ millions) Figure 37. Americas Single-Domain Heavy Chain Antibody Sales Market Share by Country in 2025 Figure 38. Americas Single-Domain Heavy Chain Antibody Revenue Market Share by Country (2020-2025) Figure 39. Americas Single-Domain Heavy Chain Antibody Sales Market Share by Type (2020-2025) Figure 40. Americas Single-Domain Heavy Chain Antibody Sales Market Share by Application (2020-2025) Figure 41. United States Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 42. Canada Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 43. Mexico Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 44. Brazil Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 45. APAC Single-Domain Heavy Chain Antibody Sales Market Share by Region in 2025 Figure 46. APAC Single-Domain Heavy Chain Antibody Revenue Market Share by Region (2020-2025) Figure 47. APAC Single-Domain Heavy Chain Antibody Sales Market Share by Type (2020-2025) Figure 48. APAC Single-Domain Heavy Chain Antibody Sales Market Share by Application (2020-2025) Figure 49. China Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 50. Japan Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 51. South Korea Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 52. Southeast Asia Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 53. India Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 54. Australia Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 55. China Taiwan Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 56. Europe Single-Domain Heavy Chain Antibody Sales Market Share by Country in 2025 Figure 57. Europe Single-Domain Heavy Chain Antibody Revenue Market Share by Country (2020-2025) Figure 58. Europe Single-Domain Heavy Chain Antibody Sales Market Share by Type (2020-2025) Figure 59. Europe Single-Domain Heavy Chain Antibody Sales Market Share by Application (2020-2025) Figure 60. Germany Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 61. France Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 62. UK Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 63. Italy Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 64. Russia Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 65. Middle East & Africa Single-Domain Heavy Chain Antibody Sales Market Share by Country (2020-2025) Figure 66. Middle East & Africa Single-Domain Heavy Chain Antibody Sales Market Share by Type (2020-2025) Figure 67. Middle East & Africa Single-Domain Heavy Chain Antibody Sales Market Share by Application (2020-2025) Figure 68. Egypt Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 69. South Africa Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 70. Israel Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 71. Turkey Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 72. GCC Countries Single-Domain Heavy Chain Antibody Revenue Growth 2020-2025 ($ millions) Figure 73. Manufacturing Cost Structure Analysis of Single-Domain Heavy Chain Antibody in 2025 Figure 74. Manufacturing Process Analysis of Single-Domain Heavy Chain Antibody Figure 75. Industry Chain Structure of Single-Domain Heavy Chain Antibody Figure 76. Channels of Distribution Figure 77. Global Single-Domain Heavy Chain Antibody Sales Market Forecast by Region (2026-2031) Figure 78. Global Single-Domain Heavy Chain Antibody Revenue Market Share Forecast by Region (2026-2031) Figure 79. Global Single-Domain Heavy Chain Antibody Sales Market Share Forecast by Type (2026-2031) Figure 80. Global Single-Domain Heavy Chain Antibody Revenue Market Share Forecast by Type (2026-2031) Figure 81. Global Single-Domain Heavy Chain Antibody Sales Market Share Forecast by Application (2026-2031) Figure 82. Global Single-Domain Heavy Chain Antibody Revenue Market Share Forecast by Application (2026-2031)
Companies Mentioned
Sino Biological
GenScript
Proteintech Group
Abiocenter
MerryBio
Pregene
Cusabio
Biocytogen
Thermo Fisher Scientific
QVQuality
HUABIO
Jackson ImmunoResearch
Methodology
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Data Sourse
Primary Source
Secondary Source
Players/Suppliers
Journals and Periodicals
Industry Experts
Government Bodies
Distributors/Traders
Annual Reports
Opinion Leaders
Presentations
Front-line Staff
Paid Databases
Marketing Executives
LPI Internal Repository
Data Analysis
Data Synthesis
Data Validation
Information Gathering
Triangulation with Data Models
Collation of Data
Reference Against Proprietary
Estimation of Key Figures
Databases
Analysis of Derived Insights
Corroboration with Industry Experts
Writing And Finishing Report
Qualitative Analysis
Qualitative Analysis
Market drivers
Market size and forecast
Market challenges
Market segmentation
Market trends
Geographical insights
Five forces analysis
Competitive landscape
Have A Question?
Provide comprehensive and accurate analysis and reports according to your exact requirements.
Contact Us
Select A Format
Single User License
USD3660
Multi Users License
USD5490
Corporate Users License
USD7320
Buy Now
Add To Cart
Or More Options：
PDF Download
Sample Request
Custom Request
Jump To Content
Description
Table Of Contents
List Of Tables
Companies Mentioned
Methodology
Have A Question?
Provide comprehensive and accurate analysis and reports according to your exact requirements.
Contact Us
17890 Castleton St. Suite 162 City of Industry, CA 91748 United States
Copyright © 2016-2025 LP Information All Rights Reserved
